This Article Full Text Full Text (PDF) All Versions of this Article: 2/2/107    most recent CIRCIMAGING.108.811752v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rudd, J. H.F. Articles by Fayad, Z. A. Search for Related Content PubMed PubMed Citation Articles by Rudd, J. H.F. Articles by Fayad, Z. A. Related Collections Pathophysiology Imaging PET and SPECT Related Article

Original Articles

Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers

A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study

James H.F. Rudd, MD, PhD, MRCP; Kelly S. Myers, MD; Sameer Bansilal, MD; Josef Machac, MD; Mark Woodward, PhD; Valentin Fuster, MD, PhD; Michael E. Farkouh, MD, MSc and Zahi A. Fayad, PhD

From the Imaging Science Laboratories (J.H.F.R., K.S.M., Z.A.F.), Cardiovascular Imaging Clinical Trials Unit (S.B., M.E.F.), Division of Nuclear Medicine (J.M.), Department of Radiology, Department of Medicine (M.W.), and The Zena and Michael A. Wiener Cardiovascular Institute and Marie Josée and Henry R. Kravis Cardiovascular Health Center (V.F.), Mount Sinai School of Medicine, New York, NY.

Correspondence to James H.F. Rudd, MD, PhD, MRCP, Division of Cardiovascular Medicine, Cambridge University, UK, jhfr2{at}cam.ac.uk or Zahi A. Fayad, Imaging Science Laboratories, Mount Sinai School of Medicine, New York, NY 10029. E-mail Zahi.Fayad@mssm.edu

Received August 3, 2008; accepted December 23, 2008.

Background— Fluorodeoxyglucose positron-emission tomography (FDG PET) imaging of atherosclerosis has been used to quantify plaque inflammation and to measure the effect of plaque-stabilizing drugs. We explored how atherosclerotic plaque inflammation varies across arterial territories and how it relates to arterial calcification. We also tested the hypotheses that the degree of local arterial inflammation measured by PET is correlated with the extent of systemic inflammation and presence of risk factors for vascular disease.

Methods and Results— Forty-one subjects underwent vascular PET/computed tomography imaging with FDG. All had either vascular disease or multiple risk factors. Forty subjects underwent carotid imaging, 27 subjects underwent aortic, 24 subjects iliac, and 13 subjects femoral imaging. Thirty-three subjects had a panel of biomarkers analyzed. We found strong associations between FDG uptake in neighboring arteries (left versus right carotid, r=0.91, P<0.001; ascending aorta versus aortic arch, r=0.88, P<0.001). Calcification and inflammation rarely overlapped within arteries (carotid artery FDG uptake versus calcium score, r=–0.42, P=0.03). Carotid artery FDG uptake was greater in those with a history of coronary artery disease (target-to-background ratio, 1.83 versus 1.61, P<0.01) and in males versus females (target-to-background ratio, 1.83 versus 1.63, P<0.05). Similar findings were also noted in the aorta and iliac arteries. Subjects with the highest levels of FDG uptake also had the greatest concentrations of inflammatory biomarkers (descending aorta target-to-background ratio versus matrix metalloproteinase 3, r=0.53, P=0.01; carotid target-to-background ratio versus matrix metalloproteinase 9, r=0.50, P=0.01). Nonsignificant positive trends were seen between FDG uptake and levels of interleukin-18, fibrinogen, and C-reactive protein. Finally, we found that the atheroprotective biomarker adiponectin was negatively correlated with the degree of arterial inflammation in the descending aorta (r=–0.49, P=0.03).

Conclusions— This study shows that FDG PET imaging can increase our knowledge of how atherosclerotic plaque inflammation relates to calcification, serum biomarkers, and vascular risk factors. Plaque inflammation and calcification rarely overlap, supporting the theory that calcification represents a late, burnt-out stage of atherosclerosis. Inflammation in one arterial territory is associated with inflammation elsewhere, and the degree of local arterial inflammation is reflected in the blood levels of several circulating biomarkers. We suggest that FDG PET imaging could be used as a surrogate marker of both atherosclerotic disease activity and drug effectiveness. Prospective, event-driven studies are now underway to determine the role of this technique in clinical risk prediction.

Key Words: atherosclerosis • imaging • inflammation • positron emission tomography • fluorodeoxyglucose • calcification

---

 

CLINICAL PERSPECTIVE

Drs Rudd and Myers contributed equally to this work.

Related Article

Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study

James H.F. Rudd, Kelly S. Myers, Sameer Bansilal, Josef Machac, Mark Woodward, Valentin Fuster, Michael E. Farkouh, and Zahi A. Fayad
Circ Cardiovasc Imaging 2009 2: 107-115. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				R. J. Gibbons, P. A. Araoz, and E. E. Williamson The Year in Cardiac Imaging J. Am. Coll. Cardiol., February 2, 2010; 55(5): 483 - 495. [Full Text] [PDF]

				A. Rominger, T. Saam, S. Wolpers, C. C. Cyran, M. Schmidt, S. Foerster, K. Nikolaou, M. F. Reiser, P. Bartenstein, and M. Hacker 18F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease J. Nucl. Med., October 1, 2009; 50(10): 1611 - 1620. [Abstract] [Full Text] [PDF]